Shen, X.; Kretz, A.-L.; Schneider, S.; Knippschild, U.; Henne-Bruns, D.; Kornmann, M.; Lemke, J.; Traub, B.
Evaluation of CDK9 Inhibition by Dinaciclib in Combination with Apoptosis Modulating izTRAIL for the Treatment of Colorectal Cancer. Biomedicines 2023, 11, 928.
https://doi.org/10.3390/biomedicines11030928
AMA Style
Shen X, Kretz A-L, Schneider S, Knippschild U, Henne-Bruns D, Kornmann M, Lemke J, Traub B.
Evaluation of CDK9 Inhibition by Dinaciclib in Combination with Apoptosis Modulating izTRAIL for the Treatment of Colorectal Cancer. Biomedicines. 2023; 11(3):928.
https://doi.org/10.3390/biomedicines11030928
Chicago/Turabian Style
Shen, Xiao, Anna-Laura Kretz, Sandra Schneider, Uwe Knippschild, Doris Henne-Bruns, Marko Kornmann, Johannes Lemke, and Benno Traub.
2023. "Evaluation of CDK9 Inhibition by Dinaciclib in Combination with Apoptosis Modulating izTRAIL for the Treatment of Colorectal Cancer" Biomedicines 11, no. 3: 928.
https://doi.org/10.3390/biomedicines11030928
APA Style
Shen, X., Kretz, A. -L., Schneider, S., Knippschild, U., Henne-Bruns, D., Kornmann, M., Lemke, J., & Traub, B.
(2023). Evaluation of CDK9 Inhibition by Dinaciclib in Combination with Apoptosis Modulating izTRAIL for the Treatment of Colorectal Cancer. Biomedicines, 11(3), 928.
https://doi.org/10.3390/biomedicines11030928